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Nonalcoholic fatty liver disease (steatosis) is the most preva-
lent liver disease in the Western world. One of the advanced
pathologies is nonalcoholic steatohepatitis (NASH), which is
associated with induction of the unfolded protein response
(UPR) and disruption of autophagic flux. However, the mecha-
nisms by which these processes contribute to the pathogenesis
of humandiseases are unclear.Herein, we identify the isoform
of the inhibitor of Bruton’s tyrosine kinase (IBTK) as a mem-
ber of the UPR, whose expression is preferentially translated
during endoplasmic reticulum (ER) stress. We found that
IBTK is located in the ER and associates with proteins LC3b,
SEC16A, and SEC31A and plays a previously unrecognized role
in phagophore initiation fromER exit sites. Depletion of IBTK
helps prevent accumulation of autophagosome intermediates
stemming from exposure to saturated free fatty acids and res-
cues hepatocytes from death. Of note, induction of IBTK and
the UPR, along with inhibition of autophagic flux, was associ-
ated with progression from steatosis to NASH in liver biopsies.
These results indicate a function for IBTK in NASH that links
autophagy with activation of the UPR.
Nonalcoholic fatty liver disease (NAFLD)3 is the most prev-
alent liver disease in the Western world, and its associated
pathologies range from simple steatosis to nonalcoholic steato-
hepatitis (NASH); hallmarks of NASH include hepatic inflam-
mation, increased liver enzymes, and fibrosis that increases the
potential to progress to cirrhosis, liver failure, and hepatocellu-
lar carcinoma (1–3). The liver plays a central role in metaboliz-
ing and processing fatty acids for export as complex lipids to the
adipose tissue for storage; however, metabolic diseases such as
obesity and insulin resistance trigger adipocytes to release
excess levels of circulating free fatty acids (FFAs) into the
serum. Elevated levels of saturated FFAs are suggested to cause
lipotoxicity in peripheral tissues, including liver, activating cel-
lular stress pathways, which can in turn lead to increased
inflammation and hepatocyte death (4, 5).
Saturated FFAs can induce the unfolded protein response
(UPR), allowing for changes in both transcriptional and trans-
lational modes of gene expression that can serve to alleviate
stresses afflicting the endoplasmic reticulum (ER) (6, 7). The
UPR is composed of sensor proteins for ER stress, including
PERK (EIF2AK3/PEK) that phosphorylates the  subunit of
eIF2 (eIF2-P), which represses global translation initiation
and lowers the influx of nascent polypeptides into the stressed
ER (8). Additionally, eIF2-P leads to preferential translation of
key UPR genes that function in stress adaptation (9). Recently,
we showed that eIF2-P by PERK results in preferential trans-
lation of the transcription factor CHOP (GADD153/DDIT3),
which plays a central role in saturated FFA-induced lipotoxicity
and hepatic inflammation (10). Increased CHOP expression
triggers a signaling pathway that induces NF-B-directed tran-
scriptional expression and consequent secretion of pro-inflam-
matory cytokines, such IL-8 and TNF, providing a linkage
between the UPR and inflammation to disease progression
(6, 7, 10). Although activation of CHOP by saturated FFAs is
suggested to play a direct role in both the hepatotoxicity and
inflammation observed during the progression of NASH, the
underlying mechanisms of hepatocellular death remain
unclear.
Recent literature has shown that autophagy is associated
with the progression of NASH (11–14). Autophagy requires
formation of double membrane vesicles that carry cytoplasmic
cargo to the lysosome for degradation (15). Hepatic autophagy
was reported to be impaired in NASH patients, as well as mice
that displayed liver steatosis due to a high fat diet (11, 12). Of
interest, although shorter term treatment of cultured human
hepatocytes with the saturated FFA palmitate triggered
autophagy, prolonged exposure led to a block in autophagic flux
and cell death (11). It was reasoned that the block in autophagic
flux contributes to the sensitivity of hepatocytes to prolonged
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exposure to saturated FFA, and it was reported that loss of
CHOP function lowered the blockage of autophagic flux trig-
gered by saturated FFA and protected hepatocytes from cell
death (11). CHOPaswell as its upstreameffector–transcription
factor ATF4 are suggested to contribute to the expression of
select genes implicated in the formation and function of
autophagosomes (16–18), which suggests that a blockage in
autophagic flux rather than lowering of autophagy per se is a
critical contributor to hepatoxicity by saturated FFAs. A role
for the UPR in the initiation of autophagy is also supported by
the finding that substitutions in eIF2 that block phosphoryla-
tion by PERK result in defective lipidation of LC3b and a con-
sequent block in phagophore initiation (19). This finding sug-
gests that theremay be additional unknown direct translational
target(s) of eIF2-P that are essential for phagophore initiation
during stress. The underlying mechanisms by which PERK and
the UPR contribute to induction of autophagy will be a central
focus of this study.
We recently identified the  isoform of inhibitor of Bruton’s
tyrosine kinase (IBTK) as being preferentially translated in
response to eIF2-P and ER stress (20). Although the biological
functions of IBTK are not yet understood, it is noted that
IBTK contains protein–protein interaction domains, includ-
ing ankyrin repeats and the BTB/POZ domain, which is sug-
gested to enable IBTK to serve as a substrate adapter for the E3
ubiquitin ligase CUL3 (21, 22). In this study, we show that
IBTK expression is rapidly induced byPERKupon exposure to
saturated FFA and that the ensuing activation of IBTK plays
an essential role in phagophore initiation by IBTK assembly
into a multisubunit complex with LC3b, SEC16A, and SEC31A
at the endoplasmic reticulum exit site (ERES). We also show
that depletion of IBTK results in impaired autophagy, along
with reduced protein secretion, resulting in suppression of
FFA-induced hepatocyte cell death. Finally, we use human liver
biopsy samples to demonstrate that theUPR-inflammation sig-
naling axis and increased IBTK expression are associated with
progression from steatosis to NASH, thereby linking the UPR,
inflammation, and inhibition of autophagic flux to disease
pathogenesis in humans.
Results
IBTK is a novel UPRmember induced by saturated FFAs
To determine whether IBTK is preferentially translated in
human hepatocytes following metabolic stress, we treated
human hepatomaHepG2 cells with palmitate or thapsigargin, a
pharmacological agent that potently induces ER stress. Follow-
ing 6 h of treatment, we performedpolysomeprofiling (Fig. 1A).
Both thapsigargin and palmitate resulted in a reduction of
heavy polysomes coincident with accumulation ofmonosomes,
indicative of lowered global translation initiation compared
with vehicle treatment. IBTKmRNA, as well as those encod-
ing preferentially translated controls ATF4 and CHOP, was
then measured by comparing the percent of each gene tran-
script in the gradient fractions (Fig. 1, B and C). After either
stress treatment, there was a significant shift of IBTKmRNA
toward large polysomes compared with vehicle, similar to the
expected increase in the ATF4 and CHOP transcripts. Interest-
ingly, IBTK was present in the heaviest polysome fractions 6
and 7 after either thapsigargin or palmitate treatment, whereas
ATF4 and CHOP were predominantly in polysome fractions
4–6. This shift of the IBTK mRNA to the heaviest polysome
fractions is consistent with the fact that IBTK has a longer
coding sequence that can accommodate more translating ribo-
somes compared with ATF4 and CHOP. HepG2 cells deleted
for PERK (PERK-KO) by using CRISPR/Cas9 retained high lev-
els of translation as viewed by heavy polysomes independent of
stress (Fig. 1, D and E) and showed only modest changes in
fraction distributions of IBTK, ATF4, or CHOPmRNAs (Fig.
1, F and G). We conclude that PERK is required for repression
of global protein synthesis, coincident with preferential trans-
lation of IBTK and UPR members in human hepatocytes in
response to ER stress triggered by lipotoxicity.
PERK and its downstream effector CHOP also trigger tran-
scriptional expression of UPR target genes to alleviate stress or
activate inflammation (8, 23). To determine whether IBTK
expressionwas also regulated at the transcriptional level during
treatment with palmitate, we generated CHOP knock-out
(CHOP-KO) HepG2 cells and exposed these cells along with
their wild-type (WT) counterparts to saturated FFAs or vehicle
(Fig. 1, H and I). IBTKmRNA and protein were induced only
inWTHepG2 cells treated with palmitate, whereas basal levels
remained unchanged betweenWT and CHOP-KO cells. These
results indicate that PERK activation and its downstream effec-
tor CHOP are also required for induced IBTKmRNA expres-
sion in the UPR.
Saturated FFAs induce cell death through inhibition of
autophagic flux
Although itwas suggested that both apoptosis and autophagy
are associated with lipotoxicity during NASH (5, 13, 24), it is
unclear whether either of these pathways play a direct role in
hepatocyte death. To determine whether apoptotic pathways
are involved, we investigated the role of caspases in hepatocyte
death during lipotoxicity by treating HepG2 cells with satu-
rated and unsaturated FFAs, either alone or in the presence of
pan-caspase inhibitor ZVAD/FMK (Fig. 2,A and B). In parallel,
we also used controls, including staurosporine, that induce apo-
ptosis and the potent ER stress agent tunicamycin. Treatment
with saturated FFAs palmitate and stearate produced a modest
increase in caspase activity, but the addition of ZVAD/FMKdid
not rescue cell death. By contrast, ZVAD/FMK blocked both
staurosporine-induced cell death and caspase 3/7 activation.
Neither the unsaturated FFAoleate nor the canonical UPR acti-
vator tunicamycin resulted in appreciable cell death after 24 h.
During apoptosis, nuclear localization of cleaved caspase 3 is
essential for breakdown of the nuclear lamina and DNA frag-
mentation (25). Although cleaved caspase 3 was localized pre-
dominantly to the nucleus after staurosporine treatment as
judged by immunocytochemistry, total cleaved caspase 3 was
reduced and retained in the cytoplasm with the addition of
ZVAD/FMK (Fig. 2C). By contrast, the low levels of caspase 3
activation determined during treatment with saturated FFAs
were coincident with caspase 3 being retained in the cytoplasm.
These results indicate that apoptosis is not the predominant
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mode of hepatocyte death following exposure to saturated
FFAs.
Inhibition of autophagic flux is linked with NASH in human
patients (11, 26). To determine whether autophagy was associ-
ated with activation of the UPR, induction of IBTK, and cell
death, we treated HepG2 cells with saturated or unsaturated
FFAs for up to 24 h and measured key markers of UPR activa-
tion as well as LC3b and P62/SQSTM1 to assess changes in
autophagy (Fig. 2, D and E). Increased levels of ATF4 and
IBTK proteins were observed by 3 h after treatment with
palmitate and 6 h of tunicamycin, prior to induction of CHOP.
Furthermore, palmitate and stearate triggered accumulation of
lipidated LC3b-II and P62, suggesting that saturated FFAs
either induced autophagy or, alternatively, blocked autophagic
flux. Oleate had only a modest effect on the UPR and did not
alter the autophagic markers, whereas treatment with tunica-
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mycin led to potent induction of the UPR and increased
LC3b-II but produced only a transient increase in P62.
To confirm whether prolonged exposure to saturated FFAs
interferes with autophagic flux as reported (11), we expressed
N-terminal GFP-LC3b inHepG2 cells and assessed its co-local-
ization with lysosomes by staining with LAMP2 (Fig. 2F). First,
we treated the HepG2 cells with chloroquine, which inhibits
proteolysis in the lysosome and hence stabilizes LC3b; 75% of
GFP-LC3b was co-localized with the lysosomal marker
LAMP2, indicating that autophagosomes were properly traf-
ficked to the lysosomes. By contrast, treatment with palmitate
disrupted autophagosome trafficking to the lysosome, with
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only 10% of GFP-LC3b being co-localized with LAMP2 despite
a robust induction of autophagy. These results are consistent
with prior reports that prolonged treatment with palmitate
leads to a block in autophagic flux, which would impair proper
trafficking of damaged macromolecules and organelles to the
lysosome for degradation.
Does disruption in the autophagic process play an active role
in hepatocyte death upon exposure to saturated FFAs? We
treated HepG2 cells with palmitate alone or in combination
with agents that disrupt either autophagy initiation (3-methy-
ladenine) or lysosomal function (chloroquine or bafilomycin
A1) for 24 h and measured cell death (Fig. 2, G and H). To
determine whether this mechanism was relevant to human
hepatocytes, we also repeated the experiment with primary
human hepatocytes. Addition of 3-methyladenine, which pre-
vents induction of autophagy by inhibiting PI3K, increased the
survival of both HepG2 cells and primary human hepatocytes,
whereas the lysosome inhibitors resulted in increased death of
HepG2 cells. Human primary hepatocytes were more sensitive
to palmitate-induced cell death (80% compared with 30% in
HepG2 cells); therefore, adding chloroquine and bafilomycin
A1 did not increase cell death further. These results suggest
that inhibition of autophagic flux, rather than inhibition of
phagophore formation per se, plays an important role in palmi-
tate-induced hepatotoxicity.
IBTK is required for autophagosome formation and
sensitizes hepatocytes to lipotoxicity
To explore the hypothesis that IBTK regulates cell survival
by induction of autophagy, we generated IBTK knockdown
(shIBTK) HepG2 cells using shRNA and measured key pro-
tein markers of stress and autophagy, in addition to cell death
following palmitate treatment (Fig. 3A). As controls, we also
knocked down ATG5, which is important for formation of the
autophagosome (27), as well as CHOP that is suggested to con-
tribute to expression of select autophagy genes. Following
palmitate exposure, each of the three gene knockdowns
resulted in decreased conversion of LC3b-I to LC3b-II and lev-
els of P62 coincident with lowered cell death (Fig. 3, A and B).
Of interest, either knockdown of IBTK or overexpression of
IBTK similarly reduced LC3b lipidation and P62 levels, sug-
gesting that the appropriate amount of IBTK expressed in
cells is critical for its function (Fig. 3C). Equivalent to depletion
of IBTK, overexpression of IBTK also suppressed the toxic-
ity of palmitate (Fig. 3D).
Earlier, we reported that knockdown of IBTK in mouse
embryo fibroblasts in the absence of environmental stress and
to a lesser extent inHepG2 cells can lead to increased apoptosis
(9). In support of this idea, we determined that the small
amounts of caspase 3/7 activity measured in HepG2 cells void
of stress were modestly elevated by knockdown of IBTK (sup-
plemental Fig. 1). A similar result was determined for HepG2
cells treated with bafilomycin A1. By contrast, the modest
amounts of caspase 3/7 activity measured in HepG2 cells
exposed to palmitate (Fig. 2A) were significantly lowered by
depletion of IBTK (supplemental Fig. 1). These results com-
binedwith our lipotoxicity results indicate that IBTK can have
differential effects on cell viability depending on the nature and
extent of the environmental stress and the affected cell types.
IBTK mRNA levels and translation were increased by the
PERK/CHOP pathway in response to palmitate (Fig. 1). Corre-
sponding expression measurements of the IBTK-depleted
cells indicated that although the levels of IBTK mRNA and
protein were lowered as expected, CHOP and its known tran-
scriptional target genes MAP1LC3B and SQSTM1 were fully
induced after palmitate treatment, indicating that IBTK func-
tions as a unique downstream effector in the UPR (Fig. 3,A and
E). Of note, mTORC1 remained repressed in all knockdowns
following palmitate treatment, asmeasured by phosphorylation
of S6 kinase, yet autophagy was not induced (Fig. 3A). These
findings indicate that IBTK is required for the induction of
autophagy during activation of the UPR by lipotoxicity, and
depletion of IBTK or its upstream regulator CHOP rescues
hepatocytes from exposure to saturated FFAs.
Both shIBTK and control (shCTRL) cells were next assayed
for accumulation of LC3b in the presence or absence of ba-
filomycin A1 or chloroquine (Fig. 3B). Depletion of IBTK
decreased conversion of LC3b-I to LC3b-II, as well as lowered
accumulation of P62 upon treatment with chloroquine. Similar
results were also observed upon overexpression of IBTK (Fig.
3C). These results suggest that IBTK is not only a downstream
UPR target but is also an essential effector in a pathway leading
to the induction of autophagy prior to LC3b lipidation.
To further test the proposed role of IBTK in phagophore
initiation, we expressed GFP-LC3b in HepG2 cells treated with
chloroquine or vehicle andmeasured the accumulation of LC3b
as judged by immunofluorescence microscopy (Fig. 3F). In the
control HepG2 (shCTRL) cells, there was a distinct punctate
pattern upon chloroquine treatment. However, knockdown of
either ATG5 or IBTK sharply lowered the detected punctate
GFP-LCb3. These results support the idea that IBTK is critical
for phagophore initiation.
We next investigated the ultrastructural changes by electron
microscopy that occurred in WT, CHOP-KO, and IBTK-KO
HepG2 cells treated with bafilomycin A1, palmitate, or vehicle
(supplemental Figs. S2–S4). Deletion of IBTK in cells in the
absence of stress resulted in loss of ER organization and an
accumulation of damaged mitochondria (supplemental Figs.
S2C and S3). Bafilomycin A1 or palmitate treatment of
IBTK-KO cells, but not control cells, led to dilation of the ER,
suggesting that IBTK is important for ER organization and
general trafficking in the adaptive response to ER stress. WT
HepG2 cells treated with bafilomycin A1 showed accumulation
of large autophagolysosomes (supplemental Fig. 2A); however,
no autophagosomes were present in either CHOP-KO or
IBTK-KO HepG2 cells treated with bafilomycin A1 (supple-
mental Figs. 2, B and C, S3 and S4). Exposure of WT HepG2
cells to palmitate also resulted in the appearance of lipid vacu-
oles throughout the cytoplasm, but a lack of autophagolyso-
somes, consistent with the observation that there was aberrant
LC3b trafficking to the lysosome (supplemental Fig. 2A). By
comparison, treatment of CHOP-KOand IBTK-KOcells with
palmitate resulted in decreased amounts of neutral lipid accu-
mulation, still without the appearance of autophagosomes
(supplemental Figs. 2, B and C, S3 and S4). These results sup-
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port the idea that the UPR plays a direct role in phagophore
formation through a signaling pathway involving CHOP and
IBTK.
IBTK induces autophagy by binding to amultisubunit protein
complex, including LC3b at the ERES
Phagophores have been suggested to form at the ER (28–32).
Because both initiation of autophagy and ER morphology are
dependent upon IBTK (Fig. 3), we wanted to address the pro-
cesses by IBTK that can contribute to phagophore formation.
We first utilized immunocytochemistry to determine the cellu-
lar location of IBTK in WT HepG2 cells treated with chloro-
quine, palmitate, or vehicle by staining for endogenous IBTK
(Fig. 4A). IBTKwas primarily co-localizedwith the ERmarker
calnexin independent of stress. To assesswhether IBTK is also
located at the site of autophagosome formation, we used GFP-
LC3b HepG2 cells and followed a similar experimental
design. IBTK co-localized with only 5% of LC3b in both
the vehicle and chloroquine-treated cells (Fig. 4B). How-
ever, upon treatment with palmitate, which would block
autophagic flux, IBTK co-localized with 90% of LC3b.
These findings indicate that IBTK co-localizes with phago-
phores initiating the ER, but not with mature autophago-
somes at the lysosome.
To better understand the mechanisms by which IBTK is
involved in phagophore initiation at the ER membrane, we
treated WT HepG2 cells with palmitate, thapsigargin, chloro-
quine, or vehicle and carried out immunoprecipitations using
antibody specific for endogenous IBTK. Isolated proteins
were then digestedwith trypsin, followed bymass spectrometry
using multidimensional protein identification technology
(MudPIT) (Fig. 4, C and D, and supplemental Table 1). RAW
LC3b-I
LC3b-II
Palmitate: _ +
shATG5
IBTKα
CHOP
ATG5
GAPDH
P-S6K
S6K
P62
_ +
shCHOP
_ +
shIBTKα
_ +
sCTRLA
E
IBTKα
2.0
1.5
1.0
0.5
0R
el
at
iv
e 
m
R
N
A 
Le
ve
ls
shCTRL shIBTKα
*
# #
CHOP
* *
15
10
5
0
shCTRL shIBTKα
MAP1LC3B
*
*
#
#
R
el
at
iv
e 
m
R
N
A 
Le
ve
ls 4
3
2
1
0
shCTRL shIBTKα
SQSTM1
R
el
at
iv
e 
m
R
N
A 
Le
ve
ls 4
3
2
1
0
*
*
#
Vehicle
Palmitate
shCTRL shIBTKα
R
el
at
iv
e 
m
R
N
A 
Le
ve
ls
B
shCTRL shIBTKα shCHOP
50
40
30
20
10
0
%
 C
el
l D
ea
th
Palmitate: 24 h
*
# #
C
V PA CQ V PA CQ V PA CQ
 shCTRL shIBTKα OE IBTKα
IBTKα
LC3b-I
LC3b-II
GAPDH
P62
#
%
 C
el
l D
ea
th
50
40
30
20
10
0
sh
CT
RL
sh
IB
TK
α
OE
-IB
TK
α
sh
CH
OP
Palmitate: 24 h
*
# # #
shATG5
D
siCTRL siATG5 siIBTKα
Ve
hi
cl
e
C
hl
or
oq
ui
ne
F
G
FP
-L
C
3b
 P
un
ct
ae
 P
er
 C
el
l
50
40
30
20
10
0
Vehicle
Chloroquine
siCTRL siATG5 siIBTKα
HepG2: GFP-LC3b
*
#
#
Figure 3. IBTK is required for the induction of autophagy. A, shCTRL, shIBTK, shCHOP, and shATG5 HepG2 cells were treated with either vehicle () or
palmitate () for 12 h, and the indicated proteinsweremeasured by immunoblot analyses. B, shCTRL, shIBTK, shCHOP, and shATG5HepG2 cells were treated
with palmitate for 24 h, and cell viability was measured by LDH release. C, control (shCTRL) and shIBTK HepG2 cells, or those overexpressing (OE) a FLAG-
tagged IBTK, were treated with vehicle (V), palmitate (PA), or chloroquine (CQ) for 24 h, and the indicated proteins were measured by immunoblot analyses.
D, shCTRL, shIBTK, and OE-IBTK HepG2 cells were treated with palmitate for 24 h, and cell viability was determined by LDH release. E, shCTRL and shIBTK
HepG2 cells were treatedwith palmitate or vehicle for 12 h, and the indicated gene transcripts weremeasured by qPCR. F,HepG2 cells stably transducedwith
GFP-LC3bwere treatedwith vehicle, chloroquine, or palmitate for 12 h, and co-localizationwith LAMP2was visualized using immunofluorescencemicroscopy
and quantified at the pixel level.
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data files from each MudPIT step were used for FASTA data-
base searching using SEQUEST HT, and the resulting dataset
was filtered to allow for a false discovery rate of 1%. SAINT
analysis was performed on the resulting peptide-spectrum
matching counts from the database searches to identify pro-
teins that displayed significant association with IBTK pre-
pared from WT cells compared with affinity carried out using
IgG control pulldowns. A total of 73 proteins were identified
that met the SAINT probability score of 0.8. These IBTK-
associated proteins include those involved in protein synthesis,
Figure 4. IBTK associates with protein complex at the ERES and induces formation of phagophores. A, HepG2 cells were treated with vehicle, chloro-
quine (CQ), or palmitate, and IBTK and the ER marker calnexin were visualized using immunofluorescence microscopy. Co-localization of IBTK and ER was
quantified at thepixel level.B,HepG2 cells stably expressingGFP-LC3bwere treatedwith vehicle, chloroquine, or palmitate, and co-localizationwith IBTKwas
visualizedusing immunofluorescencemicroscopyandquantified.C,HepG2cellswere treatedwith vehicle, chloroquine, thapsigargin, or palmitate. Cell lysates
were used in immunoprecipitation experiments with endogenous IBTK as bait. The network represents proteins, and their functional classes, pulled down
following LC/MS analysis of eluents.D,diagram showing SAINT score against fold change spectral abundance for proteins identified in LC/MS analysis of IBTK
immunoprecipitationexperiment. E, shCTRLand shSEC16AHepG2cellswere treatedwitheither vehicle () or palmitate () for 12hand the indicatedproteins
were measured by immunoblot analyses. F, control (shCTRL) and shSEC16A HepG2 cells were treated for 24 h and viability was measured by LDH release. G,
shCTRL and shSEC16A HepG2 cells were treated with palmitate or vehicle for 12h and co-localization of IBTK and canexin was visualized using immunoflu-
orescence microscopy.
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quality control, cell structure and function, RNA binding, and
vesicular transport (Fig. 4D). Among the proteins pulled down
with IBTK with the greatest degree of confidence were
SEC16A and SEC31A, two essential proteins situated in the
ERES, with functions in COPII-vesicle trafficking and sug-
gested roles in phagophore initiation (32–34). The pulldown
results were consistent with the notion that IBTK is part of
a larger complex that plays a role in phagophore formation at
the ERES.
We next addressed whether the IBTK-binding partner
SEC16A also plays a direct role in phagophore formation and
lipotoxicity. We treated HepG2 cells depleted for SEC16A
expression with either palmitate or vehicle and measured
changes in conversion of LC3b-I to LC3b-II as well as cell death
(Fig. 4, E and F). Depletion of SEC16A decreased LC3b lipida-
tion and P62 accumulation, coincident with enhanced resis-
tance to lipotoxicity. Additionally, immunocytochemical anal-
yses of the SEC16A-depleted cells HepG2 cells revealed an
altered ER morphology and consequent changes in the pattern
of IBTK localization (Fig. 4G). These results indicate that
SEC16A is important for ER organization, IBTK localization,
and induction of autophagy.
To further test whether IBTK associates with SEC16A and
LC3b, we treated WT HepG2 cells with thapsigargin, chloro-
quine, palmitate, or vehicle and then immunoprecipitated
IBTK, followed by immunoblot analyses of associated pro-
teins (Fig. 5A).We found that independent of stress, IBTKwas
complexedwith LC3b, along with SEC16A, andULK1/2, which
have been suggested to interact directly with LC3b at the ERES
and be essential for phagophore formation (32–36). These
same protein interactions were observed using reciprocal
SEC16A pulldowns, and loss of SEC16A expression resulted in
disruption of the IBTK complex (Fig. 5, B and C). These find-
ings suggest that IBTK associates with a complex, including
SEC16A, and that this complex is essential for recruitment
of a key phagophore-inducing complex involving LC3b and
ULK1/2. Although IBTK can be bound to this multisubunit
complex independent of stress as judged by pulldown experi-
ments, exposure to saturated FFAs enhances expression of
IBTK through the UPR and as a consequence its localization
to this complex in the ERES.
We also tested the association between IBTK and SEC31A
and potentially additional members of the complex by immu-
noprecipitating IBTK from HepG2 cells treated with palmi-
tate or vehicle, followed by immunoblot analyses of the bound
proteins. IBTKwas associated with SEC31A and CUL3, along
with LC3b independent of treatment with saturated FFAs (Fig.
5,D and F). However, reciprocal pulldown of SEC31A indicated
that LC3b is not part of this complex (Fig. 5E). Although knock-
down of SEC31A lowered binding of IBTK with CUL3, it did
not disrupt association of IBTK with SEC16A or LC3b (Fig.
5E). Knockdown of SEC31A also lowered LC3bI to LC3bII con-
version and reduced P62 levels in HepG2 cells treated with
palmitate (Figs. 5E and 6A). These results indicate that IBTK
can associate with distinct complexes at the ERES that partici-
pate in phagophore initiation.
IBTK and the UPR activate NF-B and secretion of cytokines
triggering lipotoxicity
Previously, we determined that treatment of hepatocytes
with saturated FFAs induces the PERK/CHOP pathway in the
UPR, leading toactivationofNF-Bbyaprocess involvingphos-
phorylation of the subunit P65/RELA at serine 536 (10).
Induced NF-B contributes to increased expression and subse-
quent secretion of TNF and IL-8; TNF secreted from hepa-
tocytes functions in a paracrine fashion, facilitating hepatocyte
cell death and also further amplification of NF-B activation,
whereas both TNF and IL-8 contribute to inflammation (10).
The precise mechanisms by which CHOP contributes to acti-
vation of NF-B in hepatocytes treated with saturated FFAs is
uncertain. It is noteworthy that expression of the inhibitory
IB was not significantly affected by loss of CHOP (10).
We reasoned that CHOP function in phagophore initiation
and accumulation of suggested toxic autophagosome interme-
diates may be contributors to CHOP activation of NF-B and
its downstream target genes. To test this idea, we determined
whether depletion of IBTK, or one of its interacting partners
at the ERES-SEC31A, also prevented induction of NF-B-di-
rected gene expression. Similar to that observed for knockdown
of CHOP, depletion of either IBTK or SEC31A blocked P65
phosphorylation at serine 536, as well as induced secretion of
TNF and IL-8 and mRNA expression of these genes (Fig. 6,
A–C). Finally, knockdown of SEC31A also thwarted death of
HepG2 cells upon prolonged exposure to palmitate as observed
for depletion of CHOP and IBTK (Fig. 6D).
We next addressed whether SEC31A, along with SEC16A,
has an important role in phagophore formation in HepG2 cells.
As noted earlier, knockdown of SEC16A lowered the levels of
LC3B-II and P62 inHepG2 cells treatedwith palmitate (Figs. 4E
and 6E). Furthermore, depletion of SEC16A sharply lowered
LC3b-II upon a block in autophagic flux during treatment with
chloroquine (Fig. 6F). Similar results were observed upon
depletion of SEC31A (Fig. 6G). These results support the idea
that both SEC16A and SEC31A participate in initiation of
autophagy.
SEC16A and SEC31A havewell documented functions in the
formation of COPII vesicles at the ERES (37), along with their
suggested role in phagophores during assembly (32–34).
Therefore, the role of these SEC proteins, and by inference
CHOP and IBTK, for activation of NF-B and hepatotoxicity
by saturated FFAs could result from the functions of these
genes in facilitating secretion of TNF and/or phagophore for-
mation. ATG5 is central for phagophore formation, as visual-
ized by lowered LC3b lipidation and P62 accumulation in
ATG5-depleted HepG2 cells treated with palmitate (Figs. 3A
and 6E). Of importance, knockdown of ATG5 blocked P65
phosphorylation upon treatment with the saturated FFA,
strongly supporting the model that NF-B activation during
lipotoxicity is dependent upon the induction of autophagy
(Fig. 6E). These findings indicate that lowered secretion of
TNF and IL-8 in the IBTK-depleted cells is not merely a
consequence of loss of COPII-directed secretion, which
occurs with disruption of the protein complexes featuring
SEC16A and SEC31A at the ERES (37).
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To address whether general secretion also involves IBTK
and associated proteins at the ERES that facilitate initiation of
autophagy, we transfected control andHepG2 cells depleted for
IBTK, CHOP, SEC16A, or SEC31A with a Gaussia luciferase
reporter construct and measured secreted luciferase activity in
the cell culturemedia following treatmentwith either vehicle of
palmitate (Fig. 6H). Depletion of each of the four gene targets
resulted in a reduction of Gaussia luciferase secretion. These
findings suggest that the assembled multisubunit protein com-
plexes containing IBTK at the ERES are integral to secretion
processes emanating from the ER, as well as the formation of
autophagosomes.
We previously showed that secreted TNF is central for hep-
atocellular death upon exposure to saturated FFAs (10). We
addressed this idea by adding recombinant TNF to WT,
shCHOP, and shIBTKHepG2 cells in the presence or absence
of palmitate treatment. There was significant death of shCHOP
and shIBTK cells only after treatment with TNF in combi-
nation with palmitate (Fig. 6I), which was accompanied by
increased phosphorylation of P65 (Fig. 6J). These results indi-
cate that IBTK is critical for cytokine expression and secretion
and consequent inhibition of autophagic flux during metabolic
stress.
UPR and NF-B are induced in human liver biopsies of NASH
patients
To address whether our proposed UPR signaling model
derived from the HepG2 and primary human hepatocyte stud-
ies is truly relevant to disease progression in human liver, we
investigated induction of theUPRand autophagy in a set of liver
biopsy samples from patients undergoing bariatric surgery.
These patients were matched for body mass index (BMI), gen-
der, and age (supplemental Table 2). Patients were categorized
after histological evaluation and standard scoring for NAFLD,
including steatosis grade, degree of fibrosis, and presence of
hepatocellular ballooning and lobular inflammation according
to the NASH clinical research network proposed system (38).
Levels of CHOP, P65, phosphorylated P65, and IBTK were
increased in the livers of patients withNAFLD (simple steatosis
and NASH) relative to normal control (Fig. 7, A–E). Addition-
ally, inhibition of autophagic flux was observed in NASH
patients asmeasured by LC3b-II conversion and P62 levels (Fig.
7, F and G), consistent with severe hepatocellular injury mark-
ers such as ballooning (Fig. 7, H and I). These findings indicate
that theUPR, includingCHOP and IBTK, andNF-B are acti-
vated in patients with NAFLD, and as the disease progresses
from simple steatosis to NASH, there is a strong correlation
with inhibition of autophagic flux.
To address whether UPR and NF-B activation are associ-
ated with increased cytokine secretion, we performed a cyto-
kine panel on serum from patients (Fig. 7, J–L, and supplemen-
tal Table 3). Levels of IL-6, IL-8, and TNF were elevated in
NASH patients, whereas only IL-6 and TNF were elevated in
those with simple steatosis. These results, along with all other
metadata collected on the human samples, were utilized to
carry out a principle component analysis (Fig. 7, M and N).
From this analysis, we identified a mixture of cell-based and
serum biomarkers that are closely related to NASH, steatosis,
or both NAFLD states. For example, CHOP, IL-8, AST, LC3b,
and P62 correlate strongly with NASH, whereas IBTK, phos-
phorylated P65, and TNF correlate with both NAFLD states
(simple steatosis and NASH).
Discussion
Accumulation of saturated FFAs and activation of the UPR
activation are common features associated with NAFLD; how-
ever, how the UPR contributes to the progression from simple
steatosis to NASH is not clear (7). This report indicates that
activation of the UPR and IBTK, in combination with inhibi-
tion of autophagic flux during prolonged exposure to saturated
FFAs, is as a key driver of hepatocellular death and the patho-
physiology of NASH (Fig. 7A). IBTK expression was induced
as part of the UPR by both translational and transcriptional
controlmechanisms (Fig. 1), and loss of IBTK in human hepa-
tocytes thwarted induction of autophagy and enhanced survival
of hepatocytes exposed to saturated FFAs (Fig. 2).
Translational control during ER stress allows for rapid
enhanced expression of IBTK and consequent assembly of a
multisubunit complex at the ERES that included key factors,
such as LC3b, ULK1/2, SEC16A, and SEC31A that served to
promote phagophore initiation (Fig. 4). In response to satu-
rated FFAs, the UPR and CHOP trigger a signaling pathway
involving NF-B, which induces transcriptional expression of
key cytokines that contribute to inflammation and cell death
(Figs. 6 and 8B). Among these cytokines, TNF is suggested to
function as an autocrine and paracrine factor that contributes
to cell death and amplifies NF-B-directed gene expression
(Fig. 8B).
Enhanced levels of IBTK are also suggested to promote for-
mation of vesicles from the ER that facilitate secretion of these
cytokines (Fig. 6). Lowered levels of secreted reporter Gaussian
luciferase upon loss of IBTK, as well as SEC16A and SEC31A,
indicate that IBTK facilitates at least a portion of the secre-
tome. IBTKmay function as amultidomain adapter protein in
the assembly of the protein complex at the ERES and/or help
direct E3 ubiquitin ligase CUL3 ubiquitylation of proteins
required for assembly or function of the complex. Importantly,
loss of SEC31A did not disrupt IBTK association with
SEC16A or LC3b, suggesting that there are distinct complexes,
including IBTK, that are situated at the ERES (Fig. 8).
Figure 5. IBTK associateswith SEC proteins. A and B,HepG2 cells were treated for 12 hwith the indicated stress compounds, and cell lysates were used for
immunoprecipitationwith IgG control (mock), IBTK, or SEC16A followed by immunoblot analysis. On the left of A, input indicates the immunoblot analyses of
total lysates. C, shCTRL and shSEC16AHepG2 cells were treated for 12 hwith vehicle or palmitate, and cell lysates were used for immunoprecipitationwith IgG
control (mock) or IBTK followed by immunoblot analysis. On the left of C, input indicates the immunoblot analyses of total lysates.D and E,HepG2 cells were
treated with palmitate or vehicle for 12 h, and cell lysates were used for immunoprecipitation with IgG control (mock), IBTK, or SEC16A, followed by
immunoblot analysis to measure the indicated proteins. On the left of D, input indicates immunoblot analyses carried out using total lysates. F, shCTRL and
shSEC31A HepG2 cells were treated with vehicle or palmitate for 12 h, and cell lysates were used for immunoprecipitation with IgG control (mock) or IBTK,
followed by immunoblot analyses to measure the indicated proteins.
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Figure 6. IBTK and the UPR activate NF-B and secretion of cytokines triggering lipotoxicity. A, control (shCTRL), shCHOP, shIBTK, and shSEC31A
HepG2 cellswere treatedwith vehicle () or palmitate () for 12 h, and cell lysateswere used for immunoblot analyses to determine the levels of the indicated
proteins. B, shCTRL, shCHOP, shIBTK, and shSEC31A HepG2 cells were treated with vehicle or palmitate for 12 h, and IL-8 and TNF release wasmeasured by
sandwich ELISA. C, shCTRL, shCHOP, and shIBTK HepG2 cells were treated with vehicle or palmitate for 12 h, and the levels of CXCL8 (IL-8) and TNFA (TNF)
mRNAs were measure by qPCR. D, shCTRL and shSEC31A HepG2 cells were treated with palmitate for 24 h, and cell viability was measured by LDH release. E,
shCTRL, shSEC16A, and shATG5 HepG2 cells were treatedwith either vehicle () or palmitate () for 12 h, and cell lysates were used for immunoblot analyses
to determine the levels of the indicated proteins. F, shCTRL and shSEC16A HepG2 cells were treated with chloroquine (CQ) or vehicle (V) for 24 h, and the
indicatedproteinsweremeasuredby immunoblot.G,HepG2cells depleted for SEC31A (shSEC31A) or control (shCTRL)were treatedwith chloroquineor vehicle
for 24 h, and the indicated proteinsweremeasured by immunoblot.H, shCTRL, shCHOP, shIBTK, shSEC16A, and shSEC31AHepG2 cells were transfectedwith
aGaussia luciferase reporter and treatedwithvehicleorpalmitate for 12h. Luciferase activitywasmeasured in the supernatant. I, cultured shCTRL, shCHOP, and
shIBTKHepG2 cellswere treated for 24 hwith recombinant TNF andpalmitate, aloneor in combination, as indicated, and cell viabilitywasmeasuredby LDH
release. J, shCTRL, shCHOP, and shIBTK HepG2 cells were treated for 24 h with recombinant TNF and/or palmitate, as indicated, and the indicated proteins
were measured by immunoblot analyses.
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Autophagy initiation and COPII-directed vesicle transport are
suggested to be linked, as depletion of IBTK prevents both the
induction of autophagy and secretion of the secreted luciferase
reporter and cytokines. The full complement of proteins func-
tioning in conjunction with IBTK in the ERES complexes is
currently unknown. Furthermore, it is not known whether
these distinct complexes are restricted to either formation of
phagophores or to protein secretion or, alternatively, there are
some commonprotein assembly steps at the ERES that contrib-
ute to both processes.
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Autophagy is often thought of as a cell survival pathway that
directs damaged organelles and misfolded proteins for degra-
dation in lysosomes (39). However, autophagy can play a direct
role in cell death, and recent studies have suggested that there
are two main processes: 1) type II autophagic cell death, which
consists of cell death accompanied by accumulation of large
secondary vacuoles, and 2) autosis, which is characterized by a
disappearance of the ER and general self-eating (40). Our
results suggest that saturated FFAs induce neither type II cell
death nor autosis, as autophagy is a key driver in hepatocellular
death without the appearance of secondary lysosomes.
A key feature of our study is the localization of IBTK to
ERES through a complex that includes LC3b, SEC16A, and
SEC31A (Fig. 4).When the hepatocytes were exposed to palmi-
tate, LC3b-II was retained at the endoplasmic reticulum with
IBTK, suggesting either a defect in phagophore elongation or
trafficking from the ERES to the lysosome. Further support that
a block in autophagy flux rather than reduced autophagy per se
is critical for the lipotoxicity of hepatocytes is that loss ofATG5,
which facilitated phagophore formation, and CHOP that can
direct expression of genes critical to formation of autophago-
somes provides for resistance to saturated FFAs. These findings
suggest that saturated FFAs induce a novel form of autophagic
cell death, perhaps a subset of autosis, which allows for the
lipidation of LC3b but interferes with LC3b trafficking from the
ER to lysosomes. Importantly, this block in autophagic flux is
coincident with increased inflammation and TNF signaling
thereby linking key features of NASH pathogenesis in a linked
signaling cascade (Fig. 8B). Although it is possible that this form
of cell death is unique to metabolic stress, it is also likely to be a
driver in other diseases states or even drug-induced liver injury
in which hepatocellular death and inflammation are prominent
pathologies.
Induction of theUPRand a block in autophagic fluxwere also
supported by our analysis of human liver biopsy samples, which
indicated that levels of IBTK, CHOP, aswell as total and phos-
phorylated P65 were increased in both simple steatosis and in
NASH (Fig. 7). Of importance, levels of LC3b-II and P62 were
significantly elevated in NASH, which were strongly associated
with hepatocellular injury markers, such as ballooning.
Therefore, we have identified biomarkers suggested to be
specific for NASH, as well as others associated with general
NAFLD. Furthermore, analyses of the liver biopsy samples
indicate that our in vitro model correlates well with the
events occurring in NAFLD. Our principal component anal-
ysis combining protein quantification, histology, and serum
analysis indicates that key factors and pathways described
herein will provide new insight into the progression of sim-
ple steatosis to NASH.
In summary, we identified IBTK as a novel preferentially
translated member of the UPR during metabolic stress, which
plays a role in both phagophore initiation and formation of
transport vesicles at the ERES, linking autophagy and secretion
to the pathogenesis of NASH. Furthermore, our study indicates
that aberrant autophagy and the consequent inhibition of
autophagic flux are key drivers in the pathogenesis of NASH at
both the cellular level and as correlative biomarkers in patient
samples. At present, no approved therapies exist to treat
NASH, and there is a need a for bettermechanistic understand-
ing of cellular targets that repress the associated pathologies
and progression of NASH. The ability to target both hepatocel-
lular death and inflammation through IBTK in the treatment
of simple steatosis and/or NASH could have therapeutic bene-
fits, and further work in the validation of this target is
warranted.
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Experimental procedures
Stable gene knockdowns and knock-outs
Stable knockdown and control cells were generated by trans-
ducingHepG2 cells with lentivirus carrying shRNA fromSigma
against shCHOP (TRCN0000364393 and TRCN0000007263),
shIBTK (TRCN0000082575 and TRCN0000082577), shATG5
(TRCN0000151963 and TRCN0000151474), shSEC16A
(TRCN0000246017), and shSEC31A (TRCN0000436177). Sta-
ble knockouts were constructed by using a plasmid from Sigma
expressing the guide RNA, CAS9, long terminal repeats, and
puromycin for CHOP (HS0000185403, GGAAATCGAGCGC-
CTGACCAGG), PERK (Hs0000302986, AATTATCAG-
CACTTTAGATGGG), or IBTK (HS0000392536, GCTTTG-
GATCTTGTAATGAAGG). Stable N-terminal GFP-LC3b
cells were constructed using a plasmid (EX-T0824-Lv103) from
GeneCopoeia (Rockville, MD). Following transduction, cells
taking up virus were selected using 10 g/ml puromycin, and
knock-out cells were sorted for single cells using flow cytom-
etry. For the Gaussia luciferase assay, PSV40-gluc control
plasmid fromNew England Biolabs (Ipswich,MA) was trans-
fected to cells, and supernatant was used tomeasure secreted
luciferase.
Cell culture andmeasurements of cell viability
Human hepatoma HepG2 cells were purchased from ATCC
and were both cultured and treated with 600 M FFAs as
described previously (10). Furthermore, to invoke ER stress or
to alter autophagy, cells were treated with 1 M thapsigargin, 2
M tunicamycin, 50M chloroquine, or 0.1M bafilomycin A1,
as indicated. Cell viability was measured using lactate dehydro-
genase (LDH) (41). Data were normalized to total LDH release
by 10% Triton X-100. Recombinant TNF (PHC03015L; Life
Technologies, Inc.) was formulated in phosphate-buffered
saline (PBS) with BSA and applied to cells as indicated in the
figure legends. Caspase 3/7 activity was measured using the
Apo-ONE homogeneous caspase 3/7 assay from Promega
(Madison, WI).
Polysome profiling
HepG2 control and PERK-KO knock-out cells were cultured
in the presence of vehicle, 600 M palmitate, or 1 M thapsi-
gargin for 6 h. 50 g/ml cycloheximide was added to each cul-
ture dish for 10 min prior to collection. Cell lysates were col-
lected and subjected to centrifugation in a 10–50% sucrose
gradient in a Beckman SW41Ti rotor for 2 h at 4 °C at 40,000
rpm. To measure RNA abundance, an absorbance of 254 nm
was monitored as described (42). ATF4, CHOP, and IBTK
mRNA levels were measured by qPCR in each of the seven
collected fractions as described (20). Firefly luciferase mRNA
was added to each fraction to facilitate normalization in the
cDNA and qPCR analysis for the transcript measurements as
described. Data are represented as the percentage of transcript
found in each fraction relative to the total for each mRNA, and
a percentage change in large polysomes (fractions 5–7) with
treatment relative to vehicle was measured.
Measurements ofmRNA by qPCR
Following the indicated compound treatments, RNA was
isolated using TRIzol reagent (Life Technologies, Inc.), and
cDNA synthesis was performed using the TaqMan RT kit (Life
Technologies, Inc.). Primers utilized for measuring mRNA lev-
els are in supplemental Table 4, and transcripts were normal-
ized to GAPDH.
Immunoblot analysis and ELISAs
Protein lysates were collected and quantified using Pierce
BCA Protein Assay kit (Thermo Fisher Scientific). Proteins
were separated by electrophoresis using 4–12% BisTris gels via
SDS-PAGE, transferred to nitrocellulose filters, and blocked for
1 h at room temperature. Membranes were incubated over-
night with the following primary antibodies: from Cell Signal-
ing Technology (Beverly, MA), ATF4 (11815S), GAPDH
(2118S), p65 (8242), p-P65 (3033), CUL3 (2759S), ULK1
(8054S), PERK (5683), ATG5 (2630S), S6K (9202S), P-S6K
(9208S), calnexin (26795), and cleaved caspase 3 (9664L); from
Santa Cruz Biotechnology (Dallas, TX), CHOP (sc-7351) and
LAMP2 (sc-18822); from Sigma, -actin (A5441); from Novus,
LC3b (NB1002220), SEC16A (NB183016), IBTK (NBP15033
and NBP188512), p62/SQSTM1 (H00008878-M01), and ULK2
(NBP133136); from Thermo Fisher Scientific, calnexin (MA3-
027); and from Abcam (Cambridge, MA), SEC31A (AB8660).
For human serum samples, the cytokine human magnetic
10-plex panel fromThermoFisher Scientific was utilized on the
LumiexMAGPIX fromEMDMillipore (Billerica,MA). Human
IL-8 and TNF in the conditioned media of HepG2 cells were
measured using R&D Systems (Minneapolis, MN) Quantikine
ELISA kits D8000C and DTA00C, respectively.
Immunoprecipitation
For immunoprecipitation analyses, cells were trypsinized,
washed once with PBS, and flash-frozen following 5 min of
incubation on ice in a hypotonic lysis buffer containing 20 mM
Hepes, 2 mM MgCl2, and 10% glycerol. Following a rapid thaw
in a pre-warmedwater bath,NaCl (150mM final concentration)
was added to cell suspensions on ice for 5 min, followed by
clarification by centrifugation using a microcentrifuge at
10,000 g for 15min. Supernatantwas transferred to proteinG
Dynabeads coated with the following primary antibodies: from
Abcam, SEC16A (ab70722) and SEC31A (AB8660); from
Novus, IBTK (NBP188512) and IgG control (3900S). After an
overnight incubation in a cold room with continuous rotation
to ensure mixing, beads were washed with a buffer containing
20 mM Hepes, 2 mM MgCl2, 10% glycerol, and 150 mM NaCl.
Supernatant was removed, and proteins associated with beads
were eluted with either urea for LC/MS analysis or with 1
SDS-PAGE buffer for immunoblot analysis.
Mass spectrometry and quantitative proteomics analysis
Mass spectrometry analysis of isolated protein complexes
pulled down with antibodies against native IBTK and peptide
sequence matching via SEQUEST HT was performed using
Proteome DiscovererTM 1.4 (Thermo Fisher Scientific), as
described previously (43). Three biological replicates were car-
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ried out for the IBTK pulldown as comparedwith IgG control.
For each biological replicate, four technical replicates were per-
formed. Protein sequence matching was performed against a
human FASTA database from Uniprot (March 16, 2014) con-
taining additional laboratory contaminant proteins, such as
proteolytic enzymes. Nonspecific interactions were eliminated
using the statistical model Significance Analysis of Interactome
(SAINT) and a stringent SAINT threshold of p 0.8 (44–46).
This statistical tool assigns the number of peptide identifica-
tions for each target protein to a probability distribution, which
is then used to measure the likelihood of biologically accurate
protein interactions.
Cell imaging
For all cellular imaging, cultured HepG2 cells were treated
with the indicated compounds, then fixed with 1 Prefer
from Anatech (San Diego), and permeabilized with 0.1% Tri-
ton X-100 for 10 min. This was followed by overnight incu-
bations with primary antibody in PBS containing 0.1% BSA,
and then a 2-h incubation with the corresponding secondary
Alexa Fluor conjugates and 10 g/ml Hoechst (33342) from
Life Technologies, Inc. Images were acquired by spinning
disk confocal microscopy on the Opera (PerkinElmer Life
Sciences) using a 60 water objective, which were trans-
ferred to Volocity (PerkinElmer Life Sciences) for three-di-
mensional rendering of the 0.5 M z-stack sections and data
quantification. Samples collected for electron microscopy
were processed and imaged by DSimaging, LLC (West Lafay-
ette, IN).
HumanNAFLD samples
Samples were collected under a study protocol that was
reviewed and approved by the Medical College of Wisconsin’s
Institutional Review Board (previous institution for S. G.). Each
participating subject gave a written Informed Consent for par-
ticipation. Subjects were morbidly obese (BMI 40 kg/m2 or
35 kg/m2 with significant co-morbidities) with prior
unsuccessful attempts to lose and maintain weight, and who
underwent bariatric surgery. A protocol intraoperative liver
biopsy was performed on all patients for histological pheno-
typing. Patients with alcohol intake 20 g/day and those
with other liver diseases based on positive disease-specific
serological tests and suggestive liver histology were ex-
cluded. Patients using drugs associated with NAFLD prior to
liver biopsy were excluded. An experienced pathologist read
the liver biopsy according to the NASH Clinical Research Net-
workworking group system (National Institutes ofHealth) (38).
Statistical analysis
Data are depicted as  S.D. unless otherwise noted. Differ-
ences between multiple groups were analyzed using analysis of
variance and a post hoc Tukey’s honest significant difference.
For all figures, p 0.05 was considered statistically significant
and is depicted using an asterisk, whereas treatment groups in
knockdown/knock-out experiments considered statistically
significant relative to the respective shCTRL treatment are
depicted by a number sign (#).
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